Literature DB >> 10737396

Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.

F E Alexander1, R F Jarrett, D Lawrence, A A Armstrong, J Freeland, D A Gokhale, E Kane, G M Taylor, D H Wright, R A Cartwright.   

Abstract

A UK population-based case-control study of Hodgkin's disease (HD) in young adults (16-24 years) included 118 cases and 237 controls matched on year of birth, gender and county of residence. The majority (103) of the cases were classified by Epstein-Barr virus (EBV) status (EBV present in Reed-Stenberg cells), with 19 being EBV-positive. Analyses using conditional logistic regression are presented of subject reports of prior infectious disease (infectious mononucleosis (IM), chicken pox, measles, mumps, pertussis and rubella). In these analyses HD cases are compared with matched controls, EBV-positive cases and EBV-negative cases are compared separately with their controls and formal tests of differences of association by EBV status are applied. A prior history of IM was positively associated with HD (odds ratio (OR) = 2.43, 95% confidence interval (CI) = 1.10-5.33) and with EBV-positive HD (OR = 9.16, 95% CI = 1.07-78.31) and the difference between EBV-positive and EBV-negative HD was statistically significant (P = 0.013). The remaining infectious illnesses (combined) were negatively associated with HD, EBV-positive HD and EBV-negative HD (in the total series, for > or =2 episodes compared with < or =1, OR = 0.45, 95% CI = 0.25-0.83). These results support previous evidence that early exposure to infection protects against HD and that IM increases subsequent risk; the comparisons of EBV-positive and EBV-negative HD are new and generate hypotheses for further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737396      PMCID: PMC2374437          DOI: 10.1054/bjoc.1999.1049

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Deprivation indices.

Authors:  B Jarman; P Townsend; V Carstairs
Journal:  BMJ       Date:  1991-08-31

2.  Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.

Authors:  B G Sleckman; P M Mauch; R F Ambinder; R Mann; G S Pinkus; M E Kadin; B Sherburne; A Perez-Atayde; I Thior; N Mueller
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-12       Impact factor: 4.254

3.  Epstein-Barr viral DNA in tissues of Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; R A Warnke; D T Purtilo; J Sklar
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

4.  A cohort study of cancer following infectious mononucleosis.

Authors:  R R Connelly; B W Christine
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Epidemiology of Hodgkin's disease.

Authors:  B MacMahon
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

6.  Characteristics in youth indicative of adult-onset Hodgkin's disease.

Authors:  R S Paffenbarger; A L Wing; R T Hyde
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

Review 7.  Epidemiology of Hodgkin's disease.

Authors:  N Gutensohn; P Cole
Journal:  Semin Oncol       Date:  1980-06       Impact factor: 4.929

8.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

9.  Hodgkin's disease in patients with previous infectious mononucleosis.

Authors:  G Kvåle; E A Høiby; E Pedersen
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

10.  Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

Authors:  N Rosdahl; S O Larsen; J Clemmesen
Journal:  Br Med J       Date:  1974-05-04
View more
  24 in total

1.  Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study.

Authors:  Julie L Kasperzyk; Ellen T Chang; Brenda M Birmann; Peter Kraft; Tongzhang Zheng; Nancy E Mueller
Journal:  Am J Epidemiol       Date:  2011-08-01       Impact factor: 4.897

2.  Childhood use of antimicrobials and risk of Hodgkin lymphoma: a Danish register-based cohort study.

Authors:  Henrik Hjalgrim; Signe Holst Søegaard; Lisa Lyngsie Hjalgrim; Klaus Rostgaard
Journal:  Blood Adv       Date:  2019-05-14

3.  HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.

Authors:  Henrik Hjalgrim; Klaus Rostgaard; Paul C D Johnson; Annette Lake; Lesley Shield; Ann-Margaret Little; Karin Ekstrom-Smedby; Hans-Olov Adami; Bengt Glimelius; Stephen Hamilton-Dutoit; Eleanor Kane; G Malcolm Taylor; Alex McConnachie; Lars P Ryder; Christer Sundstrom; Paal Skytt Andersen; Ellen T Chang; Freda E Alexander; Mads Melbye; Ruth F Jarrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

4.  Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Rachel K Fonstad; Richard F Ambinder; Greta R Bunin; Julie A Ross; Logan G Spector; Seymour Grufferman
Journal:  Int J Cancer       Date:  2014-03-18       Impact factor: 7.396

Review 5.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

6.  CNS Hodgkin lymphoma.

Authors:  Elizabeth R Gerstner; Lauren E Abrey; David Schiff; Andrés J M Ferreri; Andrew Lister; Silvia Montoto; Richard Tsang; Eckhard Thiel; Francesc Graus; Dirk Behringer; Gerald Illerhaus; Susan Weaver; Patrick Wen; Alfredo Voloschin; Nancy Lee Harris; Tracy T Batchelor
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

7.  The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.

Authors:  R F Jarrett; A S Krajewski; B Angus; J Freeland; P R Taylor; G M Taylor; F E Alexander
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

Review 8.  Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.

Authors:  Justine M Kahn; Kara M Kelly
Journal:  Pediatr Blood Cancer       Date:  2018-03-30       Impact factor: 3.167

Review 9.  Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.

Authors:  Grace Y Lam; Brendan P Halloran; Anthea C Peters; Richard N Fedorak
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

10.  Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Authors:  Sally L Glaser; Margaret L Gulley; Christina A Clarke; Theresa H Keegan; Ellen T Chang; Sarah J Shema; Fiona E Craig; Joseph A Digiuseppe; Ronald F Dorfman; Risa B Mann; Hoda Anton-Culver; Richard F Ambinder
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.